TY - JOUR
T1 - Toxicity of inorganic nanomaterials in biomedical imaging
AU - Li, Jinxia
AU - Chang, Xueling
AU - Chen, Xiaoxia
AU - Gu, Zhanjun
AU - Zhao, Feng
AU - Chai, Zhifang
AU - Zhao, Yuliang
N1 - Funding Information:
This work was financially supported by MOST ( 2012CB932601,2010CB933904 ) and NSFC ( 11305182,21301176,21277037 ).
PY - 2014/7
Y1 - 2014/7
N2 - Inorganic nanoparticles have shown promising potentials as novel biomedical imaging agents with high sensitivity, high spatial and temporal resolution. To translate the laboratory innovations into clinical applications, their potential toxicities are highly concerned and have to be evaluated comprehensively both in vitro and in vivo before their clinical applications. In this review, we first summarized the in vivo and in vitro toxicities of the representative inorganic nanoparticles used in biomedical imagings. Then we further discuss the origin of nanotoxicity of inorganic nanomaterials, including ROS generation and oxidative stress, chemical instability, chemical composition, the surface modification, dissolution of nanoparticles to release excess free ions of metals, metal redox state, and left-over chemicals from synthesis, etc. We intend to provide the readers a better understanding of the toxicology aspects of inorganic nanomaterials and knowledge for achieving optimized designs of safer inorganic nanomaterials for clinical applications.
AB - Inorganic nanoparticles have shown promising potentials as novel biomedical imaging agents with high sensitivity, high spatial and temporal resolution. To translate the laboratory innovations into clinical applications, their potential toxicities are highly concerned and have to be evaluated comprehensively both in vitro and in vivo before their clinical applications. In this review, we first summarized the in vivo and in vitro toxicities of the representative inorganic nanoparticles used in biomedical imagings. Then we further discuss the origin of nanotoxicity of inorganic nanomaterials, including ROS generation and oxidative stress, chemical instability, chemical composition, the surface modification, dissolution of nanoparticles to release excess free ions of metals, metal redox state, and left-over chemicals from synthesis, etc. We intend to provide the readers a better understanding of the toxicology aspects of inorganic nanomaterials and knowledge for achieving optimized designs of safer inorganic nanomaterials for clinical applications.
KW - Gold nanoparticles
KW - Inorganic materials
KW - Iron nanoparticles
KW - Medical imaging
KW - Nanomedicine
KW - Nanotoxicity
KW - QDs
KW - Upconversion nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=84901989065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901989065&partnerID=8YFLogxK
U2 - 10.1016/j.biotechadv.2013.12.009
DO - 10.1016/j.biotechadv.2013.12.009
M3 - Review article
C2 - 24389087
AN - SCOPUS:84901989065
SN - 0734-9750
VL - 32
SP - 727
EP - 743
JO - Biotechnology Advances
JF - Biotechnology Advances
IS - 4
ER -